u/Chevyimpala2000

Reddit r/ValueInvesting
· tracked since Jan 2026
Calls
1
Win Rate
0.0%
return
-26.3%
Calls 1 1 Posts tracked · 0.0/day
Calls
7d 0
30d 0
90d 0
Win Rate 0% Long 1 Short 0
Win Rate
7d 100%
30d 0%
90d 0%
Average Return -26.3% Long Return -26.3% Short Return -
Average Return
7d +6.0%
30d -16.1%
90d -36.3%
Visual Insights Log in to see more
Result
Result
Sort
Theme Stance
Ticker
Side
Mentions
First Call
Call Price
P&L
Thesis
Theme
Source
NVO 1ST Novo Nordisk A/S Novo Nordisk A/S
Long
Jan 09
$58.81
-26.3%
NVO oral GLP-1 lead, cheap at 15 PE
The author claims Novo Nordisk is the biggest value play of 2026 because its new oral GLP-1 launched before Eli Lilly's competing product, positioning NVO to dominate the market. The mechanism is that an earlier oral entrant captures market share in the obesity/diabetes drug market, driving growth. The stated catalyst is the oral launch and the valuation support is a 15 PE, which the author sees as leaving massive room to grow. No specific risk is stated.
GLP-1 / Obesity
REDDIT
Showing 1 of 1 calls · sorted by mentions

u/Chevyimpala2000 has 1 trade ideas tracked on Buzzberg across 1 tickers since January 2026. Most covered: NVO.

Historical call returns are modeled from recorded ideas and stored prices, not actual brokerage portfolio returns. Check the evaluated call set and horizon; past results do not establish future prediction accuracy. Explore our data and methodology